Get started
Author

Ruud Ubink

Observed institution: Byondis BV (Netherlands)
ORCID: 0000-0003-0774-0581
Observed ORCID: 0000-0003-0774-0581
OpenAlex ID: A5081777682
Preclinical Profile of BYON3521 Predicts an Effective and Safe MET Antibody–Drug Conjugate
2023 · Patrick G. Groothuis, Daniëlle C.H. Jacobs, et al. · Molecular Cancer Therapeutics · 13
PDF
Abstract 6921: Phosphonate-antibody-drug conjugates, a novel immunostimulatory class of ADCs driving inside-out activation of Vγ9Vδ2 T cells leading to selective tumor cell killing
2026 · Mary J. van Helden, Genny Filliciotto, et al. · Cancer Research · 1
Supplementary Data from Preclinical Profile of BYON3521 Predicts an Effective and Safe MET Antibody–Drug Conjugate
2025 · Patrick G. Groothuis, Daniëlle C.H. Jacobs, et al.
954 Phosphonate-antibody-drug conjugates: a novel immunostimulatory class of ADCs driving inside-out activation of Vγ9Vδ2 T cells leading to selective tumor cell killing
2025 · Mary JVan Helden, Genny Filiciotto, et al. · Journal for ImmunoTherapy of Cancer
PDF
Supplementary Data from Preclinical profile of BYON3521 predicts an effective and safe c-MET-antibody-drug conjugate
2024 · Patrick G. Groothuis, Daniëlle C.H. Jacobs, et al.
Supplementary Data from Preclinical profile of BYON3521 predicts an effective and safe c-MET-antibody-drug conjugate
2024 · Patrick G. Groothuis, Daniëlle C.H. Jacobs, et al.
Data from Preclinical profile of BYON3521 predicts an effective and safe c-MET-antibody-drug conjugate
2024 · Patrick G. Groothuis, Daniëlle C.H. Jacobs, et al.
Supplementary Data from Preclinical Profile of BYON3521 Predicts an Effective and Safe MET Antibody–Drug Conjugate
2023 · Patrick G. Groothuis, Daniëlle C.H. Jacobs, et al.
Supplementary Data from Preclinical Profile of BYON3521 Predicts an Effective and Safe MET Antibody–Drug Conjugate
2023 · Patrick G. Groothuis, Daniëlle C.H. Jacobs, et al.
Supplementary Data from Preclinical Profile of BYON3521 Predicts an Effective and Safe MET Antibody–Drug Conjugate
2023 · Patrick G. Groothuis, Daniëlle C.H. Jacobs, et al.
Data from Preclinical Profile of BYON3521 Predicts an Effective and Safe MET Antibody–Drug Conjugate
2023 · Patrick G. Groothuis, Daniëlle C.H. Jacobs, et al.
Works count: 11
Citation count: 14
H-index: 1
I10-index: 1
Year
Topic
Type